The FDA announced today that it has expanded the indication of Bristol-Myers Squibb's anticancer medication nivolumab (Opdivo) to include the treatment of patients with metastatic squamous non-small cell lung cancer with progression on or after platinum-based chemotherapy.
Worried about potential drug shortages? There's an app for that.
Better chemotherapy drugs lead to increased usage prior to breast operations over last 5 years.
Study examines link between caffeine intake and reduced symptoms of multiple sclerosis.
Interferon-free, all-oral drug regimens result in high rates of sustained virologic response for patients co-infected with hepatitis C virus and HIV.
Raulo Frear, PharmD, general manager of OmedaRx, discusses developing trends in medication compliance.
Mortality rates also affected by age and poor nutrition.
Expanded use would include treatment of patients with advanced squamous non-small cell lung cancer who received prior therapy.
Compound can monitor biochemical processes involved with protein kinases.
Many physicians still use technique that fails to detect deep tissue lesions near the chest wall.
Study reveals optimistic findings for patients without other options for targeted cancer therapy.
Study finds that 61 to 82% of patients treated with experimental drug achieved undetectable viral replication levels.
Preventing exposures to blood and body fluids is critical to preventing occupationally acquired HIV.
Men who had testicular cancer also more likely to develop higher risk prostate cancers.
From supplying super-specialized implants to getting a new product on pharmacy shelves within hours of approval, distributors have an important role in health care.
A patient's hospital readmission likelihood relies more heavily on community factors than care at discharge, according to a study published in Health Services Research.
Five pharmacy schools received kudos from the CEO of the American Pharmacists Association for earning the highest rates of participation in the Pharmacists Provide Care Campaign.
Michael R. Hess, attorney with Bass Berry & Sims and outside general counsel to many of the largest independent specialty pharmacy companies, discusses how to overcome the hurdles that hinder patient access to specialty medications.
Study finds fewer women would support less frequent screening if they were found to be at lower risk.
Cell surface protein found to promote cancer growth.
Patient readmissions are often related to expected surgical complications after discharge, rather than poor care coordination.
Next generation chemotherapy may offer effective earlier treatment for disease.
The FDA today approved Novartis Pharmaceuticals' panobinostat (Farydak) for the treatment of patients with multiple myeloma who have received at least 2 prior standard therapies.
Changes to Medicare Part B, Part C, and Part D regulations affect 3 specific areas that may impact pharmacy operations.
Conduct needs to match ethical standards for pharmaceutical industry in Europe, study finds.
Experimental drug found to be so powerful and universally effective, it may lead to an unconventional vaccine.
Study finds shared decision making and accommodation of patient preferences improves quality.
Delivery system kills chemotherapy-resistant cancer stem cells and prevents secondary tumor formation.
Specialty pharmacies need to ensure that certain protocols are in place for product shipment and storage.